Kiniksa Corp (KNSA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Kiniksa Pharmaceuticals tadqiqot markazlari bilan hamkorlik orqali kam uchraydigan kasalliklar uchun terapiyalarni ishlab chiqmoqda va immun disfunksiyalarini tuzatishga qaratilgan agentlarni sinovdan o'tkazmoqda. Biznesning ekologik profili standart darajada bo'lib, laboratoriya chiqindilarini utilizatsiya qilish bilan cheklangan. Model yurak-qon tomir va autoimmun buzilishlarni davolashga (Arcalyst) qaratilgan kompleks yondashuvga tayanadi, bunda ko'rsatkich 0.01 hisoblanadi. Quyida ko'rsatilgan narx trayektoriyasi ushbu biofarmatsevtika aktivining bozor dinamikasini vizuallashtiradi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_KNSA_-_Kiniksa-Pharmaceuticals_-_Long-Term-Debt-to-Capital "KNSA: Kiniksa Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Kiniksa Pharmaceuticals (KNSA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati kiniksa.com|KNSA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Kiniksa Pharmaceuticals|KNSA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Kiniksa|Tezkor likvidlik ko‘rsatkichi kiniksa.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Kiniksa Pharmaceuticals, Ltd. - KNSA
Ushbu ko'rsatkich bir yildan ortiq muddatli kredit majburiyatlarining kapitalga nisbatini o'lchab, kompaniyaning qarz moliyalashtirishga bog'liqligini aks ettiradi. Uzoq muddatli qarzlarning sof aktivlarga nisbatini tahlil qilish Kiniksa Pharmaceuticals (KNSA) kompaniyasining maqsadli immunologiya sohasiga kengayishi va Arcalyst distribyutsiya tarmog'ini kengaytirish bilan bog'liq xavflarni baholash imkonini beradi hamda agressiv o'sish va moliyaviy barqarorlik o'rtasidagi muvozanatni ochib beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biocryst.com|Uzoq muddatli qarzning o'z kapitaliga nisbati VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA - Uzoq muddatli qarzning kapitalga nisbati|RIGL: Uzoq muddatli qarzning kapitalga nisbati|ANAB - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ENGN (enGene Holdings Inc)|Uzoq muddatli qarzning kapitalga nisbati RAPT|Uzoq muddatli qarzdorlikning kapitalga nisbati aerovatetx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|Uzoq muddatli qarzning kapitalga nisbati kyvernatx.com KYTX|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cabaletta Bio Inc. CABA|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Theratechnologies, Inc (THTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|CLYM: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATYR|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|IMA - Uzoq muddatli qarzning kapitalga nisbati|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic Inc (IMUX)|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati inflarx.de (IFRX)|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX (Akari Therapeutics PLC) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT (Bolt Biotherapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzning kapitalga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revbiosciences.com REVB|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Affimed Therapeutics - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ALLK|HOOK (hookipapharma.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati